Jun 2026 (Q2 FY26) — Aug 11, 2026
Absci Q2 FY26 — Positive ABS-201 Interim Data and Eli Lilly Partnership
Read the full callAbsci (ABSI) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Absci earnings: last reported Tue, 11 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 0.32 | −46.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -10741.5 | −5447.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -33.2 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$8.54 +3.52% · +$0.29
Performance +88.5% 1Y
1Y: $4.53 on 17 Oct 2025 → $8.54. High $11.62 (2 Jul 2026), low $2.3 (12 Mar 2026).
- Previous close
- $8.25
- 52-week range
- $2.3 – $11.62
- One year
- +77.55%
Overview
- Symbol
- ABSI
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Absci earnings calls (ABSI)
Financials
What the filings say
Net profit, year on year: −9% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 0 |
| Operating profit | -29 | -30 | -28 | -31 | -30 | -31 | -31 | -34 |
| Operating margin | −1698.7% | −4477.3% | −2351.9% | −5293.9% | −7977.3% | −4775.5% | −14347.0% | −10741.5% |
| Other income | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -27 | -29 | -26 | -30 | -29 | -30 | -30 | -33 |
| Tax rate | −0.1% | −0.1% | 0.0% | −0.4% | −0.4% | 0.6% | −0.1% | −0.1% |
| Net profit | -27 | -29 | -26 | -31 | -29 | -30 | -30 | -33 |
| EPS ($ per share) | -0.24 | — | -0.21 | -0.24 | -0.20 | — | -0.19 | -0.21 |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -90 | -191 | -296 | -406 | -510 | -625 |
| Total liabilities | 22 | 60 | 47 | 41 | 34 | 27 |
| Fixed assets | 9 | 52 | 53 | 41 | 29 | 21 |
| Investments | — | — | — | — | 71 | 124 |
| Total assets | 89 | 426 | 321 | 217 | 214 | 216 |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Cash from operations | -11 | -61 | -81 | -65 | -72 | -93 |
| Cash from investing | -2 | -67 | -127 | 82 | -42 | -50 |
| Cash from financing | 71 | 336 | 5 | -4 | 83 | 106 |
| Net cash flow | 58 | 208 | -203 | 13 | -31 | -37 |
| Capital expenditure | -2 | -38 | -16 | -1 | -0 | -1 |
| Free cash flow | -13 | -99 | -98 | -65 | -73 | -94 |
Insider filings
35 filings between Nov 30, 2025 and Oct 12, 2026.
Open market
decisions to buy or sellPurchases
$933.2K
5 purchases by 4 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 12
- Award — granted as compensation
- 1
- Option exercise — converted options into shares
- 17
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Pangalos Menelas N | $406.5K | — | May 13, 2026 |
| Busch Andreas | $229.0K | — | Mar 12, 2026 |
| Szela Mary T | $148.9K | — | Jun 30, 2026 |
| VAN HOUTEN FRANS | $148.8K | — | Dec 5, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Bedrick Todd SVP, CAO | Tax withheld | 22,325 | $226.8K |
| Oct 12, 2026 | McClain Sean Chief Executive Officer | Tax withheld | 23,293 | $236.7K |
| Oct 12, 2026 | Jonasson Zachariah CFO / CBO | Tax withheld | 387 | $3.9K |
| Aug 31, 2026 | Jonasson Zachariah CFO / CBO | Tax withheld | 8,320 | $72.5K |
| Jun 30, 2026 | Szela Mary T Director | Purchase | 12,900 | $148.9K |
| Jun 24, 2026 | McClain Sean Chief Executive Officer | Tax withheld | 59,896 | $603.5K |
| Jun 4, 2026 | Szela Mary T Director | Award | 8,400 | $0 |
| Jun 4, 2026 | MCGINNIS KAREN K Director | Award | 10,100 | $0 |
| Jun 4, 2026 | Pangalos Menelas N Director | Award | 10,100 | $0 |
| Jun 4, 2026 | Sirosh Joseph Director | Award | 10,100 | $0 |
| Jun 4, 2026 | Rabinovitsj Daniel A Director | Award | 10,100 | $0 |
| Jun 4, 2026 | VAN HOUTEN FRANS Director | Award | 10,100 | $0 |
| May 31, 2026 | Jonasson Zachariah CFO / CBO | Tax withheld | 8,319 | $56.2K |
| May 13, 2026 | Pangalos Menelas N Director | Purchase | 37,453 | $200.7K |
| Mar 12, 2026 | Busch Andreas Chief Innovation Officer | Purchase | 100,000 | $229.0K |
| Mar 3, 2026 | Bedrick Todd SVP, CAO | Tax withheld | 5,282 | $14.8K |
| Mar 3, 2026 | Walker Shelby J. Chief Legal Officer | Tax withheld | 9,825 | $27.5K |
| Mar 3, 2026 | Jonasson Zachariah CFO / CBO | Tax withheld | 10,848 | $30.4K |
| Mar 3, 2026 | McClain Sean Chief Executive Officer | Tax withheld | 25,316 | $70.9K |
| Mar 3, 2026 | Busch Andreas Chief Innovation Officer | Tax withheld | 1,257 | $3.5K |
| Mar 2, 2026 | Bedrick Todd SVP, CAO | Award | 49,600 | $0 |
| Mar 2, 2026 | Jonasson Zachariah CFO / CBO | Award | 135,400 | $0 |
| Mar 2, 2026 | Walker Shelby J. Chief Legal Officer | Award | 90,300 | $0 |
| Mar 2, 2026 | McClain Sean Chief Executive Officer | Award | 406,200 | $0 |
| Mar 2, 2026 | Pangalos Menelas N Director | Award | 5,800 | $0 |
| Feb 27, 2026 | Pangalos Menelas N Director | Purchase | 75,095 | $205.8K |
| Feb 23, 2026 | McClain Sean Chief Executive Officer | Tax withheld | 267,008 | $707.6K |
| Feb 23, 2026 | McClain Sean Chief Executive Officer | Option exercise | 396,399 | $479.6K |
| Feb 3, 2026 | Busch Andreas Chief Innovation Officer | Tax withheld | 1,469 | $4.4K |
| Feb 2, 2026 | Jonasson Zachariah CFO / CBO | Tax withheld | 17,496 | $52.3K |
| Feb 2, 2026 | McClain Sean Chief Executive Officer | Tax withheld | 26,761 | $80.0K |
| Feb 2, 2026 | Bedrick Todd SVP, CAO | Tax withheld | 3,659 | $10.9K |
| Jan 28, 2026 | Bedrick Todd SVP, CAO | Award | 15,000 | $0 |
| Dec 5, 2025 | VAN HOUTEN FRANS Director | Purchase | 40,000 | $148.8K |
| Nov 30, 2025 | Jonasson Zachariah CFO / CBO | Tax withheld | 8,320 | $26.4K |
| Oct 14, 2025 | Busch Andreas Chief Innovation Officer | Tax withheld | 3,092 | $11.4K |
| Oct 14, 2025 | Bedrick Todd SVP, CAO | Tax withheld | 21,950 | $80.8K |
| Oct 14, 2025 | Jonasson Zachariah CFO / CBO | Tax withheld | 387 | $1.4K |
| Oct 14, 2025 | McClain Sean Chief Executive Officer | Tax withheld | 23,293 | $85.7K |
| Sep 22, 2025 | Bedrick Todd SVP, CAO | Purchase | 10,000 | $27.0K |
| Sep 22, 2025 | Pangalos Menelas N Director | Purchase | 95,785 | $254.8K |
| Aug 31, 2025 | Jonasson Zachariah CFO / CBO | Tax withheld | 8,319 | $19.9K |
| Jul 28, 2025 | Busch Andreas Chief Innovation Officer | Purchase | 50,000 | $152.0K |
| Jun 11, 2025 | Pangalos Menelas N Director | Award | 14,500 | $0 |
| Jun 11, 2025 | VAN HOUTEN FRANS Director | Award | 14,500 | $0 |
| Jun 11, 2025 | MCGINNIS KAREN K Director | Award | 14,500 | $0 |
| Jun 11, 2025 | Sirosh Joseph Director | Award | 14,500 | $0 |
| Jun 11, 2025 | Rabinovitsj Daniel A Director | Award | 14,500 | $0 |
| May 31, 2025 | Jonasson Zachariah CFO / CBO | Tax withheld | 5,194 | $13.8K |
| Mar 3, 2025 | Bedrick Todd SVP, CAO | Award | 29,700 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Absci Corp
Free account. Everything above stays public.
Write why you follow Absci Corp and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading